Optimising Isotope Selection for Scalable Radiopharmaceutical Commercialisation
- Evaluating isotope availability, production capacity, and logistics for reliable clinical and commercial use
- Aligning isotope half-life, emission type, and energy with therapeutic goals and pharmacokinetics
- Addressing regulatory, technical, and cost considerations for efficient scale-up and market readiness